A 58-year-old man with a history of two months of steroid treatment for ANCA-related crescentic glomerulonephritis presented with a gluteal abscess and fever. Computed tomography (CT) showed a 1 cm-sized cavitary lesion in the right lung. Culture of the gluteal abscess indicated Nocardia farcinica infection and he was referred to F-18 FDG PET/CT to evaluate the extent of the disease [Figure 1]. N. farcinica is a Gram-positive, partially acid-fast by Ziehl– Nielsen staining and Gomori methenamine silver-positive aerobic actinomycete which is found worldwide in soil and water [Figure 2].N. farcinica is a relatively rare cause of nocardiosis particularly in immunocompromised patients and tends to be more virulent than the other Nocardia species. Nocardiosis can affect multiple body systems, most frequently the lungs, central nervous system, and the skin with the ability to cause disseminated disease. The treatment usually consists of a 6-week course of induction phase with intravenous antibiotics and maintenance therapy for at least 1 year. Because nocardiosis is a rare infection, only a few reports have described the lesions of Nocardia species on FDG PET/CT imaging.[3–8] FDG PET/CT scan showing extensive inflammation on multiple abscess foci of N. farcinica infection on the legs was reported in a recent study by Zhang etal. The advantages of FDG PET/CT to localize infection not only includes shorter imaging times with better spatial resolution as compared to leukocyte imaging; but also rules out the risks and errors caused by withdrawing, labeling a readministration of blood product. The influx of inflammatory cells is responsible for FDG accumulation in pulmonary nocardiosis on PET scan and may mimic lung cancer, in particular squamous cell carcinoma with cavitation. Although the standard uptake value cannot differentiate infection from malignancy, corresponding CT images may help to differentiate the two. Pulmonary nocardiosis typically manifests with consolidations and nodules/masses with or without cavitation especially in the lower lobes. Pleural and chest wall involvement is seen in a small number of patients. Furthermore, mediastinal or hilar lymphadenopathy is not a feature of nocardiosis.[7,10] Pertinent patient history (with emphasis on patient infectious history, treatment, immunocompromised state, and procedures) together with the symptoms may elucidate the underlying etiology leading to abnormal FDG uptake. In line with other studies, whole-body F-18 FDG PET/CT might help distinguish rare infections from malignancy and is used to assess not only localized infection, but also the extent of disease. FDG PET/CT may have a role in guiding sample site selection for suspicious lesions and also compromises a unique possibility in the monitoring of therapy efficacy and directing therapy duration in patients with nocardiosis especially in immunocompromised patients when the therapy is prolonged for a long time [Figure 1].[6,11,12]
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
1. Budzik JM, Hosseini M, Mackinnon AC Jr, Taxy JB. Disseminated Nocardia farcinica
:Literature review and fatal outcome in an immunocompetent patient. Surg Infect (Larchmt) 2012;13:163–70.
2. Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, Vázquez G. Infection caused by Nocardia farcinica
:Case report and review. Eur J Clin Microbiol Infect Dis 2000;19:205–12.
3. Bowman C, Davies H, Wilmore S. Disseminated nocardiosis in a liver transplant patient. Br J Hosp Med (Lond) 2017;78:720–1.
4. Zhang L, Yang Y, Huang S. Disseminated Nocardia farcinica
infection in a patient with EGPA receiving hormonotherapy. Lancet Infect Dis 2021;21:148.
5. Playe M, Einfalt M, Toch SR, Froissart A, Bodardel G. 18F-FDG imaging of a case of disseminated nocardiosis. Clin Nucl Med 2020;45:55–6.
6. Erdemir RU, Elri T, Sahin H, Sami Salihoglu Y, Aras M, Cabuk M. Disseminated nocardia infection mimicking malignancy on FDG PET/CT. Rev Esp Med Nucl Imagen Mol 2015;34:268–9.
7. Mascarenhas NB, Lam D, Lynch GR, Fisher RE. PET imaging of cerebral and pulmonary Nocardia
infection. Clin Nucl Med 2006;31:131–3.
8. Zhao K, Dong MJ, Sheng ZK, Liu KF, Yang SY, Liu ZF, et al. Elevated uptake of 18F-FDG in PET/CT imaging of a Nocardia
pleural nodule. Clin Imaging 2012;36:383–5.
9. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation –Current and emerging clinical applications. Clin Radiol 2015;70:787–800.
10. Kanne JP, Yandow DR, Mohammed TL, Meyer CA. CT findings of pulmonary nocardiosis. AJR Am J Roentgenol 2011;197:W266–72.
11. Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A. The use of (18) F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013;2013:623036.
12. Longhitano A, Alipour R, Khot A, Bajel A, Antippa P, Slavin M, et al. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant. Transpl Infect Dis 2021;23:e13547.